Editorial Expression of Concern: Intraarterial transplantation of human umbilical cord blood mononuclear cells is more efficacious and safer compared with umbilical cord mesenchymal stromal cells in a rodent stroke model (Stem Cell Research & Therapy, (2014), 5, 2, (45), 10.1186/scrt434);Intraarterial transplantation of human umbilical cord blood mononuclear cells is more efficacious and safer compared with umbilical cord mesenchymal stromal cells in a rodent stroke model

Stem Cell Research and Therapy

Volumn 5, Issue 2, 2014, Pages

  Karlupia, Neha ^a,b   Manley, Nathan C ^a   Prasad, Kameshwar ^b   Schäfer, Richard ^a   Steinberg, Gary K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 2; INTERLEUKIN 6; MESSENGER RNA; PHOSPHATE BUFFERED SALINE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; CELL SUBPOPULATION; CELL TRANSPLANTATION; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; HEMISPHERIC DOMINANCE; IMMUNOPHENOTYPING; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; MESENCHYMAL STEM CELL; MIDDLE CEREBRAL ARTERY OCCLUSION; MONONUCLEAR CELL; MORTALITY; MOTOR COORDINATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PATIENT SAFETY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT MODEL; RISK REDUCTION; SENSORIMOTOR NEUROPATHY; SHAM PROCEDURE; UMBILICAL CORD BLOOD; UMBILICAL CORD BLOOD MONONUCLEAR CELL; ANIMAL; CELL DIFFERENTIATION; COMPARATIVE STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOLOGY; DISEASE MODEL; HUMAN; INFARCTION, MIDDLE CEREBRAL ARTERY; INTRAARTERIAL DRUG ADMINISTRATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PHYSIOLOGY; PROCEDURES; RANDOMIZATION; RAT; TRANSPLANTATION; WISTAR RAT;

ANIMALS; CELL DIFFERENTIATION; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INFUSIONS, INTRA-ARTERIAL; LEUKOCYTES, MONONUCLEAR; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 84899458045     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/s13287-024-03661-z     Document Type: Erratum

References (103)

1. The successful treatment of severe aplastic anemia with autologous cord blood transplantation. Fruchtman SM, Hurlet A, Dracker R, Isola L, Goldman B, Schneider BL, Emre S, Biol Blood Marrow Transplant 2004 10 741 742 10.1016/j.bbmt.2004.07.003 15505604
2. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A, Esperou H, Thierry D, Socie G, Lehn P, Cooper S, English D, Kurtzberg J, Bard J, Boyse E, N Engl J Med 1989 321 1174 1178 10.1056/NEJM198910263211707 2571931
3. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Locatelli F, Rocha V, Reed W, Bernaudin F, Ertem M, Grafakos S, Brichard B, Li X, Nagler A, Giorgiani G, Haut PR, Brochstein JA, Nugent DJ, Blatt J, Woodard P, Kurtzberg J, Rubin CM, Miniero R, Lutz P, Raja T, Roberts I, Will AM, Yaniv I, Vermylen C, Tannoia N, Garnier F, Ionescu I, Walters MC, Lubin BH, Gluckman E, et al. Blood 2003 101 2137 2143 10.1182/blood-2002-07-2090 12424197
4. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C, Remberger M, Michel G, Arcese W, Dallorso S, Tiedemann K, Busca A, Chan KW, Kato S, Ortega J, Vowels M, Zander A, Souillet G, Oakill A, Woolfrey A, Pay AL, Green A, Garnier F, Ionescu I, Wernet P, Sirchia G, Rubinstein P, Chevret S, Gluckman E, Blood 2001 97 2962 2971 10.1182/blood.V97.10.2962 11342418
5. Human cord blood: a source of transplantable stem cells? Hows JM, Marsh JC, Bradley BA, Luft T, Coutinho L, Testa NG, Dexter TM, Bone Marrow Transplant 1992 9 105 108 1354517
6. Multi-lineage expansion potential of primitive hematopoietic progenitors: superiority of umbilical cord blood compared to mobilized peripheral blood. Lewis ID, Verfaillie CM, Exp Hematol 2000 28 1087 1095 10.1016/S0301-472X(00) 00515-4 11008022
7. Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor. Ringden O, Okas M, Uhlin M, Uzunel M, Remberger M, Mattsson J, Bone Marrow Transplant 2008 42 643 648 10.1038/bmt.2008.239 18762760
8. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, Jacobsen N, Ruutu T, de Lima M, Finke J, Frassoni F, Gluckman E, Acute Leukemia Working Party of European Blood and Marrow Transplant Group; Eurocord-Netcord Registry, N Engl J Med 2004 351 2276 2285 10.1056/NEJMoa041469 15564544
9. Non-haematological uses of cord blood stem cells. Harris DT, Br J Haematol 2009 147 177 184 10.1111/j.1365-2141.2009.07767.x 19796266
10. Embryonic-like stem cells from umbilical cord blood and potential for neural modeling. McGuckin C, Forraz N, Baradez MO, Basford C, Dickinson AM, Navran S, Hartgerink JD, Acta Neurobiol Exp (Wars) 2006 66 321 329 17269167
11. Umbilical cord blood cell transplantation after brain ischemia: from recovery of function to cellular mechanisms. Rosenkranz K, Meier C, Ann Anat 2011 193 371 379 10.1016/j.aanat.2011.03.005 21514122
12. Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions. Yang WZ, Zhang Y, Wu F, Min WP, Minev B, Zhang M, Luo XL, Ramos F, Ichim TE, Riordan NH, Hu X, J Transl Med 2010 8 75 10.1186/1479-5876-8-75 20682053
13. Human umbilical cord blood-derived mononuclear cell transplantation: case series of 30 subjects with hereditary ataxia. Yang WZ, Zhang Y, Wu F, Zhang M, Cho SC, Li CZ, Li SH, Shu GJ, Sheng YX, Zhao N, Tang Y, Jiang S, Jiang S, Gandjian M, Ichim TE, Hu X, J Transl Med 2011 9 65 10.1186/1479-5876-9-65 21575250
14. Umbilical cord stem cell therapy for cerebral palsy. Ramirez F, Steenblock DA, Payne AG, Darnall L, Med Hypotheses Res 2006 3 679 686
15. A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study. Kang KS, Kim SW, Oh YH, Yu JW, Kim KY, Park HK, Song CH, Han H, Cytotherapy 2005 7 368 373 10.1080/14653240500238160 16162459
16. Experimental treatment of stroke in spontaneously hypertensive rats by CD34+ and CD34- cord blood cells. Boltze J, Kowalski I, Geiger K, Reich D, Gunther A, Buhrle C, Egger D, Kamprad M, Emmrich F, Geriatr Med Sci 2005 3 1 15
17. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos J, Chopp M, Stroke 2001 32 2682 2688 10.1161/hs1101.098367 11692034
18. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Koh SH, Kim KS, Choi MR, Jung KH, Park KS, Chai YG, Roh W, Hwang SJ, Ko HJ, Huh YM, Kim HT, Kim SH, Brain Res 2008 1229 233 248 18634757
19. Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. Liao W, Xie J, Zhong J, Liu Y, Du L, Zhou B, Xu J, Liu P, Yang S, Wang J, Han Z, Han ZC, Transplantation 2009 87 350 359 10.1097/TP.0b013e318195742e 19202439
20. Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia. Lim JY, Jeong CH, Jun JA, Kim SM, Ryu CH, Hou Y, Oh W, Chang JW, Jeun SS, Stem Cell Res Ther 2011 2 38 10.1186/scrt79 21939558
21. Human umbilical mesenchymal stem cells promote recovery after ischemic stroke. Lin YC, Ko TL, Shih YH, Lin MY, Fu TW, Hsiao HS, Hsu JY, Fu YS, Stroke 2011 42 2045 2053 10.1161/STROKEAHA.110.603621 21566227
22. Early intracerebral and intra-arterial transplantation of human umbilical cord blood cells into an ischemic rat brain model. Lobel DA, Hadman PR, Sanberg PR, Borlongan CV, Exp Neurol 2003 181 97
23. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. Taguchi A, Soma T, Tanaka J, Kanda T, Nishimura H, Yosikawa H, Tsukamoto Y, Fujimori Y, Stern DM, Naritomi H, Matsuyama T, J Clin Invest 2004 114 330 338 10.1172/JCI200420622 15286799
24. Infusion of human umbilical cord blood cells in a rat model of stroke dose dependently rescues behavioral deficits and reduces infarct volume. Vendrame M, Cassadt J, Newcomb J, Butler T, Pennypacker KR, Zigova T, Sanberg PR, Willing AE, Stroke 2004 35 2390 2395 10.1161/01.STR.0000141681.06735.9b 15322304
25. Transplantation of a novel cell line population of umbilical cord blood stem cells ameliorates neurological deficits associated with ischemic brain injury. Xiao J, Nan Z, Motooka Y, Low W, Stem Cell Dev 2005 14 722 733 10.1089/scd.2005.14.722
26. Human umbilcal cord blood cells do not improve sensorimotor or cognitive outcome following transient middle cerebral artery occlusion in rats. Makinen S, Kekarainen T, Nystedt J, Liimatainen T, Huhtala T, Narvanen A, Laine J, Jolkkonen J, Brain Res 2006 1123 207 215 10.1016/j.brainres.2006.09.056 17070789
27. Human cord blood CD34+ cells and behavioral recovery following focal cerebral ischemia in rats. Nystedt J, Makinen S, Laine J, Jolkkonen J, Acta Neurobiol Exp (Wars) 2006 66 293 300 17265691
28. Lack of migration and neurological benefits after infusion of umbilical cord blood cells in ischemic brain injury. Zawadzka M, Lukasiuk K, Machaj EK, Pojda Z, Kaminska B, Acta Neurobiol Exp (Wars) 2009 69 46 51 19325640
29. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Borlongan CV, Hadman M, Sanberg CD, Sanberg PR, Stroke 2004 35 2385 3389 10.1161/01.STR.0000141680. 49960.d7 15345799
30. Phenotypic and functional comparison of monocytes from cord blood and granulocyte colony-stimulating factor-mobilized apheresis products. Sorg RV, Andres S, Kogler G, Fischer J, Wernet P, Exp Hematol 2001 29 1289 1294 10.1016/S0301-472X(01)00735-4 11698124
31. Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Mayani H, Lansdorp PM, Stem Cells 1998 16 153 165 10.1002/stem.160153 9617891
32. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, Yoder MC, Blood 2004 104 2752 2760 10.1182/blood-2004-04-1396 15226175
33. Mesenchymal progenitor cells in human umbilical cord blood. Erices A, Conget P, Minguell JJ, Br J Haematol 2000 109 235 242 10.1046/j.1365-2141.2000. 01986.x 10848804
34. UC blood-derived mesenchymal stromal cells: an overview. Flynn A, Barry F, O'Brien T, Cytotherapy 2007 9 717 726 10.1080/14653240701584578 17917891
35. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH, Blood 2004 103 1669 1675 10.1182/blood-2003-05-1670 14576065
36. Multipotent stem cells from umbilical cord: cord is richer than blood! Secco M, Zucconi E, Vieira NM, Fogaca LL, Cerqueira A, Carvalho MD, Jazedje T, Okamoto OK, Muotri AR, Zatz M, Stem Cells 2008 26 146 150 10.1634/stemcells. 2007-0381 17932423
37. Optimization of isolation and further characterization of umbilical-cord-blood-derived very small embryonic/epiblast-like stem cells (VSELs). Zuba-Surma EK, Klich I, Greco N, Laughlin MJ, Ratajczak J, Ratajczak MZ, Eur J Haematol 2010 84 34 46 10.1111/j.1600-0609.2009.01352.x 19758351
38. Early appearance of stem/progenitor cells with neural-like characteristics in human cord blood mononuclear fraction cultured in vitro. Habich A, Jurga M, Markiewicz I, Lukomska B, Bany-Laszewicz U, Domanska-Janik K, Exp Hematol 2006 34 914 925 10.1016/j.exphem.2006.03.010 16797419
39. Potential for access to embryonic-like cells from human umbilical cord blood. McGuckin CP, Forraz N, Cell Prolif 2008 41 31 40 18181943
40. A novel, neural potential of non-hematopoietic human umbilical cord blood stem cells. Domanska-Janik K, Buzanska L, Lukomska B, Int J Dev Biol 2008 52 237 248 10.1387/ijdb.072315kd 18311714
41. Neural commitment of cord blood stem cells (HUCB-NSC/NP): therapeutic perspectives. Domanska-Janik K, Habich A, Sarnowska A, Janowski M, Acta Neurobiol Exp (Wars) 2006 66 279 291 17265690
42. Human cord blood-derived hematopoietic and neural-like stem/progenitor cells are attracted by the neurotransmitter GABA. Zangiacomi V, Balon N, Maddens S, Tiberghien P, Versaux-Botteri C, Deschaseaux F, Stem Cells Dev 2009 18 1369 1378 10.1089/scd.2008.0367 19327013
43. Mesenchymal stromal cells from umbilical cord blood. Bieback K, Kluter H, Curr Stem Cell Res Ther 2007 2 310 323 10.2174/157488807782793763 18220915
44. Mesenchymal stem/progenitor cells in human umbilical cord blood as support for ex vivo expansion of CD34(+) hematopoietic stem cells and for chondrogenic differentiation. Wang JF, Wang LJ, Wu YF, Xiang Y, Xie CG, Jia BB, Harrington J, McNiece IK, Haematologica 2004 89 837 844 15257936
45. Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. Kim DW, Staples M, Shinozuka K, Pantcheva P, Kang SD, Borlongan CV, Int J Mol Sci 2013 14 11692 11712 10.3390/ijms140611692 23727936
46. Neuronal replacement from endogenous precursors in the adult brain after stroke. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O, Nat Med 2002 8 963 970 10.1038/nm747 12161747
47. Hypothermia and brain-derived neurotrophic factor reduce glutamate synergistically in acute stroke. Berger C, Schabitz WR, Wolf M, Mueller H, Sommer C, Schwab S, Exp Neurol 2004 185 305 312 10.1016/j.expneurol.2003.10.008 14736512
48. A CamKIIalpha iCre BAC allows brain-specific gene inactivation. Casanova E, Fehsenfeld S, Mantamadiotis T, Lemberger T, Greiner E, Stewart AF, Schutz G, Genesis 2001 31 37 42 10.1002/gene.1078 11668676
49. Reelin controls progenitor cell migration in the healthy and pathological adult mouse brain. Courtes S, Vernerey J, Pujadas L, Magalon K, Cremer H, Soriano E, Durbec P, Cayre M, PLoS One 2011 6 20430 10.1371/journal.pone.0020430 21647369
50. Reelin and stroke. Jin K, Reelin Glycoprotein: Structure, Biology, and Roles in Health and Disease New York: Springer, Fatemi SH, 2008 411 420
51. Brain-derived neurotrophic factor reduces cortical cell death by ischemia after middle cerebral artery occlusion in the rat. Ferrer I, Krupinski J, Goutan E, Martí E, Ambrosio S, Arenas E, Acta Neuropathol 2001 101 229 238 11307622
52. Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. Gorski JA, Zeiler SR, Tamowski S, Jones KR, J Neurosci Res 2003 23 6856 6865
53. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Seiler A, Schneider M, Forster H, Roth S, Wirth EK, Culmsee C, Plesnila N, Kremmer E, Radmark O, Wurst W, Bornkamm GW, Schweizer U, Conrad M, Cell Metab 2008 8 237 248 10.1016/j.cmet.2008.07.005 18762024
54. Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides. Ursini F, Maiorino M, Valente M, Ferri L, Gregolin C, Biochim Biophys Acta 1982 710 197 211 10.1016/0005- 2760(82)90150-3 7066358
55. Transport of epidermal growth factor in the stroke-injured brain. Wang Y, Cooke MJ, Lapitsky Y, Wylie RG, Sachewsky N, Corbett D, Morshead CM, Shoichet MS, J Control Release 2011 149 225 235 10.1016/j.jconrel.2010.10.022 21035512
56. Reelin-deficient mice show impaired neurogenesis and increased stroke size. Won SJ, Kim SH, Xie L, Wang Y, Mao XO, Jin K, Greenberg DA, Exp Neurol 2006 198 250 259 10.1016/j.expneurol.2005.12.008 16438965
57. Reversible middle cerebral artery occlusion without crainiectomy in rats. Longa EZ, Weinstein PR, Carlson S, Cummins R, Stroke 1989 20 84 91 10.1161/01.STR.20.1.84 2643202
58. Surgical models of stroke induced by intraluminal filament implantation. Wang-Fisher Y, Divani AA, Prado R, Koetzner L, Manual of Stroke Models in Rats Boca Raton, FL: CRC Press, Wang-Fischer Y, 2008 133 158
59. Isolation of mononuclear cells from human cord blood by Ficoll-Paque density gradient. Jaatinen T, Laine J, Current Protocols in Stem Cell Biology, Wiley Interscience; John Wiley & Sons, Inc, Elefanty A, Gregory R, Patient R, Schlaeger T, Snyder E, Yamashita Y, 2007 2A 1.1-2A.1.4
60. Umbilical cord blood cells. Newcomb JD, Willing AE, Sanberg PR, Methods in Molecular Biology, Neural Cell Transplantation Humana Press; Springer Science Publisher, Scolding NJ, Gordon D, 2009 549 119 136 10.1007/978-1-60327-931-4-9
61. The isolation and culture of human umbilical cord blood derived mesenchymal stem cells under low oxygen conditions: mesenchymal stem cell assays and applications. Laitinen A, Nystedt J, Laitinen S, Methods Mol Biol 2011 698 63 73 10.1007/978-1-60761-999-4-6 21431511
62. Clinical application of four and five-color flow cytometry lymphocyte subset immunophenotyping. Alamo AL, Melnick SJ, Cytometry 2000 42 363 370 10.1002/1097-0320(20001215)42:6<363::AID-CYTO1003>3.0.CO;2-E 11135290
63. Isotype controls in the analysis of lymphocytes and CD34+ stem and progenitor cells by flow cytometry: time to let go! Keeney M, Gratama JW, Chin-Yee IH, Sutherland DR, Cytometry 1998 34 280 283 10.1002/(SICI)1097- 0320(19981215)34:6<280::AID-CYTO6>3.0.CO;2-H 9879645
64. 8 color, 10-parameter flow cytometry to elucidate complex leukocyte heterogeneity. Roederer M, Rosa SD, Gerstein R, Anderson M, Bigos M, Stovel R, Nozaki T, Parks D, Herzenberg L, Cytometry 1997 29 328 339 10.1002/(SICI)1097- 0320(19971201)29:4<328::AID-CYTO10>3.0.CO;2-W 9415416
65. Optimized multiparametric immunophenotyping of umbilical cord blood cells by flow cytometry. Basford C, Forraz N, McGuckin C, Nature Protocols 2010 5 1337 1346 10.1038/nprot.2010.88 20595961
66. U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures. Stelzer GT, Marti G, Hurley A, McCoy P Jr, Lovett EJ, Schwartz A, Cytometry 1997 30 214 230 10.1002/(SICI)1097-0320(19971015)30: 5<214::AID-CYTO2>3.0.CO;2-H 9383095
67. Sensorimotor and cognitive consequences of middle cerebral artery occlusion in rats. Markgraf CG, Green EJ, Hurwitz BE, Morikawa E, Dietrich WD, McCabe PM, Ginsberg MD, Schneiderman N, Brain Res 1992 575 238 246 10.1016/0006-8993(92)90085-N 1571783
68. Correlation between motor impairement and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. Rogers DC, Campbell CA, Stretton JL, Mackay KB, Stroke 1997 28 2060 2066 10.1161/01.STR.28.10.2060 9341719
69. Systemic augmentation of alphaB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation. Arac A, Brownell SE, Rothbard JB, Chen C, Ko RM, Pereira MP, Albers GW, Steinman L, Steinberg GK, Proc Natl Acad Sci U S A 2011 108 13287 13292 10.1073/pnas.1107368108 21828004
70. Early delineation of ischemic tissue in rat brain cryosections by high contrast staining. Vogel J, Mobius C, Kuschinsky W, Rosenblum WI, Stroke J Cereb Circ 1999 30 1134 1141 10.1161/01.STR.30.5.1134
71. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Kelly S, Bliss TM, Shah AK, Sun GH, Ma M, Foo WC, Masel J, Yenari MA, Weissman IL, Uchida N, Palmer T, Steinberg GK, Proc Natl Acad Sci U S A 2004 101 11839 11844 10.1073/pnas.0404474101 15280535
72. Minimal criteria for defining multipotent mesenchymal stromal cells: The International Society for Cellular Therapy position statement. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, Deans RJ, Keating A, Prockop DJ, Horwitz EM, Cytotherapy 2006 8 315 317 10.1080/14653240600855905 16923606
73. Molecular mechanisms of neuroprotective action of immunosuppressants: facts and hypotheses. Kaminska B, Gaweda-Walerych K, Zawadzka M, J Cell Mol Med 2004 8 45 58 10.1111/j.1582-4934.2004.tb00259.x 15090260
74. Immunodeficiency reduces neural stem/progenitor cell apoptosis and enhances neurogenesis in the cerebral cortex after stroke. Saino O, Taguchi A, Nakagomi T, Nakano-Doi A, Kashiwamura S, Doe N, Nakagomi N, Soma T, Yoshikawa H, Stern DM, Okamura H, Matsuyama T, J Neurosci Res 2010 88 2385 2397 20623538
75. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. Willing AE, Lixian J, Milliken M, Poulos S, Zigova T, Song S, Hart C, Sanchez-Ramos J, Sanberg PR, J Neurosci Res 2003 73 296 307 10.1002/jnr.10659 12868063
76. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Li Y, Chen J, Chen XG, Wang L, Gautam SC, Xu YX, Katakowski M, Zhang LJ, Lu M, Janakiraman N, Chopp M, Neurology 2002 59 514 523 10.1212/WNL.59.4.514 12196642
77. Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Li Y, Chen J, Wang L, Lu M, Chopp M, Neurology 2001 56 1666 1672 10.1212/WNL.56.12.1666 11425931
78. Intravenous mesenchymal stem cell therapy for traumatic brain injury. Harting MT, Jimenez F, Xue H, Fischer UM, Baumgartner J, Dash PK, Cox CS, J Neurosurg 2009 110 1189 1197 10.3171/2008.9.JNS08158 19301973
79. Systemic and coronary delivery of marrow stromal cells for cellular cardiomyoplasty: advantages and precautions. Burstein BL, Shum-Tim D, Chiu RC, Basic Appl Myol 2003 13 7 10
80. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Bieback K, Kern S, Kluter H, Eichler H, Stem Cells 2004 22 625 634 10.1634/stemcells.22-4-625 15277708
81. Assessment of neuroprotective effects of human umbilical cord blood mononuclear cell subpopulations in vitro and in vivo. Boltze J, Reich DM, Hau S, Reymann KG, Strassburger M, Lobsien D, Wagner DC, Kamprad M, Stahl T, Cell Transplant 2012 21 723 737 10.3727/096368911X586783 21929866
82. Human umbilical cord blood cells have trophic effects on young and aging hippocampal neurons in vitro. Chen N, Newcomb J, Garbuzova-Davis S, Davis Sanberg C, Sanberg PR, Willing AE, Aging Dis 2010 1 173 190 21234285
83. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. Chen J, Li Y, Katakowski M, Chen X, Wang L, Lu D, Lu M, Gautam SC, Chopp M, J Neurosci Res 2003 73 778 786 10.1002/jnr.10691 12949903
84. Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. Shen LH, Li Y, Chen J, Zacharek A, Gao Q, Kapke A, Lu M, Raginski K, Vanguri P, Smith A, Chopp M, J Cereb Blood Flow Metab 2007 27 6 13 10.1038/sj.jcbfm.9600311 16596121
85. Brain derived neurotrophic factor and insulin like growth factor-1 attenuate upregulation of nitric oxide synthase and cell injury following trauma to the spinal cord: an immunohistochemical study in the rat. Sharma HS, Nyberg F, Westman J, Alm P, Gordh T, Lindholm D, Amino Acids 1998 14 121 129 10.1007/BF01345252 9871451
86. Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice. Chen J, Zacharek A, Zhang C, Jiang H, Li Y, Roberts C, Lu M, Kapke A, Chopp M, J Neurosci 2005 25 2366 2375 10.1523/JNEUROSCI.5071-04.2005 15745963
87. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. Hill WD, Hess DC, Martin-Studdard A, Carothers JJ, Zheng J, Hale D, Maeda M, Fagan SC, Carroll JE, Conway SJ, J Neuropathol Exp Neurol 2004 63 84 96 14748564
88. The neuroblast and angioblast chemotaxic factor SDF-1(CXCL12) expression is briefly up regulated by reactive astrocytes in brain following neonatal hypoxic-ischemic injury. Miller JT, Bartley JH, Wimborne HJ, Walker AL, Hess DC, Hill WD, Carroll JE, BMC Neurosci 2005 6 63 10.1186/1471-2202-6-63 16259636
89. The chemokine SDF-1/CXCL12 contributes to the 'homing' of umbilical cord blood cells to a hypoxic-ischemic lesion in the rat brain. Rosenkranz K, Kumbruch S, Lebermann K, Marschner K, Jensen A, Dermietzel R, Meier C, J Neurosci Res 2010 88 1223 1233 19937807
90. Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury. Sun L, Lee J, Fine HA, J Clin Invest 2004 113 1364 1374 10.1172/JCI200420001 15124028
91. Human umbilical cord blood cells decrease microglial survival in vitro. Jiang L, Womble T, Saporta S, Chen N, Sanberg CD, Sanberg PR, Willing AE, Stem Cells Dev 2010 19 221 228 10.1089/scd.2009.0170 19788371
92. Microglia: a sensor for pathological events in the CNS. Kreutzberg GW, Trends Neurosci 1996 19 312 318 10.1016/0166-2236(96)10049-7 8843599
93. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. Wakabayashi K, Nagai A, Sheikh AM, Shiota Y, Narantuya D, Watanabe T, Masuda J, Kobayashi S, Kim SU, Yamaguchi S, J Neurosci Res 2010 88 1017 1025 19885863
94. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Harris DT, Schumacher MJ, Locascio J, Besencon FJ, Olson GB, DeLuca D, Shenker L, Bard J, Boyse EA, Proc Natl Acad Sci U S A 1992 89 10006 10010 10.1073/pnas.89.21.10006 1438190
95. Umbilical cord blood mononuclear cell transplantation for neonatal hypoxic-ischemic encephalopathy. Pimentel-Coelho PM, Rosado-de-Castro PH, da Fonseca LM, Mendez-Otero R, Pediatr Res 2012 71 464 473 10.1038/pr.2011.59 22430382
96. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Tang Q, Bluestone JA, Nat Immunol 2008 9 239 244 10.1038/ni1572 18285775
97. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S, Giese T, Veltkamp R, Nat Med 2009 15 192 199 10.1038/nm.1927 19169263
98. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Brunstein CG, Miller JS, Cao Q, McKenna DH, Hippen KL, Curtsinger J, Defor T, Levine BL, June CH, Rubinstein P, Rubinstein P, McGlave PB, Blazar BR, Wagner JE, Blood 2011 117 1061 1070 10.1182/blood-2010-07-293795 20952687
99. CD4(+)CD25(+) immunoregulatory T cells: new therapeutics for graft-versus-host disease. Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL, J Exp Med 2002 196 401 406 10.1084/jem.20020090 12163568
100. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Taylor PA, Lees CJ, Blazar BR, Blood 2002 99 3493 3499 10.1182/blood.V99.10.3493 11986199
101. In vivo-activated CD103+ CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host disease. Zhao D, Zhang C, Yi T, Lin CL, Todorov I, Kandeel F, Forman S, Zeng D, Blood 2008 112 2129 2138 10.1182/blood-2008-02- 140277 18550852
102. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K, Stem Cells 2006 24 1294 1301 10.1634/stemcells.2005-0342 16410387
103. Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells. Siegel G, Kluba T, Hermanutz-Klein U, Bieback K, Northoff H, Schafer R, BMC Med 2013 11 146 10.1186/1741-7015-11-146 23758701